MBO Partenaires buys BCF Life Sciences

The deal was valued between €55-60m, Unquote understands. MBO Partenaires acquired a 49.9% stake in BCF, a source familiar with the situation confirmed.  

The company's managers, Jacques Pidoux and Renaud Sergheraert, together with investor Henri Lagarde – the previous owner of pet food business Royal Canin – have retained the remaining stake. 

MBO Partenaires will provide an equity ticket in excess of €15m, investing via its MBO Capital 4 fund.

The GP recently bought Groupe Location Transport, a France-based construction equipment rental and transportation service.

Previous funding 
Siparex and Unigrains completed a carve-out of the business, previously known as Bretagne Chimie Fine, from parent company Diana Ingrédients in 2005. Siparex retained a majority stake.

Four years later, Céréa became a minority investor in the group via its mezzanine funds.

Siparex and Unigrains sold their stakes in BCF in 2012. The business underwent an MBI backed by Céréa and Sodero as minority investors.  

Company
Founded in 1986, BCF specialises in the extraction of natural amino acids and their derivatives for the pharmaceutical and healthcare industries.

Headquartered in Pleucadeuc, the business has facilities in Peru and Thailand, and generates more than 60% of its turnover overseas. It has a headcount of 125.

People
MBO Partenaires – Xavier de Prévoisin (partner).
BCF Life Sciences – Jacques Pidoux (president); Renaud Sergheraert (director).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• France
• Industrials
• Exits
• France
• MBO Partenaires
• Secondary buyout